Time elapsed between ICU admission and AFT (days)
|
8.8 (9.9)
|
9.0 (6.8)
|
0.96
|
Time between BC and AFT (days)*
|
0.4 (0.5)
|
2.8 (0.8)
|
<0.01
|
AFT duration (days)
|
9.2 (6.0)
|
9.1 (6.4)
|
0.95
|
Echinocandin therapy duration (days)
|
6.7 (4.7)
|
5.7 (4.2)
|
0.54
|
Fluconazole therapy duration (days)
|
2.6 (5.1)
|
3.4 (5.2)
|
0.62
|
Septic shock (N. [%])
|
31 (79.5)
|
6 (50.0)
|
0.04
|
RRT (N. [%])
|
22 (56.4)
|
4 (33.3)
|
0.16
|
SOFA D1
|
8.8 (3.0)
|
8.4 (3.0)
|
0.14
|
PCT D1 (pg/L)
|
3.6 (6.6)
|
4.2 (10.6)
|
0.56
|
Proven bacterial infection prior to AFT (N. [%])
|
14 (46.7)
|
9 (42.8)
|
0.79
|
Outcomes Length of ICU stay (days)
|
21.4 (15.7)
|
25.6 (22.4)
|
0.47
|
MV duration (days)
|
15.7 (13.3)
|
22.4 (24.7)
|
0.22
|
Vasoactive support duration while receiving AFT (days)
|
3.8 (2.9)
|
2.3 (2.6)
|
0.11
|
ICU mortality (N. [%])
|
20 (51.2)
|
6 (50.0)
|
0.93
|
In-hospital mortality (N. [%])
|
25 (64.1)
|
9 (75.0)
|
0.14
|